Youlanda Duggar
Youlanda Duggar is a Contract Specialist at Nac Pharmaceuticals (36E797). Youlanda is associated with 3 contracts. Nac Pharmaceuticals (36E797) has $386,930,950 in total awards. Activity spans Pharmaceutical Preparation Manufacturing.
Person Profile
Contracting officer information and contact details
Youlanda Duggar
Contract Specialist
Phone
+1 (555) 000-0000Agency
Nac Pharmaceuticals (36E797)
Code: 36E797
Department Of Veterans Affairs (va) › Department Of Veterans Affairs
Last seen
Dec 8, 2025
Most recent solicitation activity
Role Type
Contract specialistContracting Officer Overview
Industry focus, set-aside activity, and contract history for this federal contracting professional.
AI Professional Profile
Youlanda Duggar serves as a Contract Specialist for the Department of Veterans Affairs, operating under Nac Pharmaceuticals (36E797), where she plays a pivotal role in securing critical pharmaceutical supplies for enrolled veterans nationwide. She manages the full lifecycle of procurement actions fo...
Youlanda Duggar serves as a Contract Specialist for the Department of Veterans Affairs, operating under Nac Pharmaceuticals (36E797), where she plays a pivotal role in securing critical pharmaceutical supplies for enrolled veterans nationwide. She manages the full lifecycle of procurement actions for prescription medications, including chronic disease therapies, acute care treatments, and specialty pharmaceuticals, ensuring compliance with federal acquisition regulations and VA healthcare delivery standards. Her work directly supports the agency’s mission to maintain uninterrupted access to essential drugs by executing timely, legally compliant contracts that prioritize supply chain resilience and therapeutic efficacy. Duggar maintains consistent, high-volume contracting relationships with leading pharmaceutical manufacturers and distributors, including Avkare LLC, Progenics Pharmaceuticals Inc., Dr. Reddy’s Laboratories, Inc., Golden State Medical Supply, Inc., and Seqirus USA Inc. These partnerships reflect a focus on established industry players capable of meeting stringent quality, regulatory, and distribution requirements for FDA-approved medications. Her contracting patterns emphasize reliability, scalability, and adherence to cGMP standards, with a preference for vendors demonstrating proven capacity in bulk pharmaceutical production and nationwide logistics. Duggar’s procurement portfolio reflects a 100% non-set-aside approach, with no use of 8(a), HUBZone, SDVOSB, or other socioeconomic programs. Her contracting strategy prioritizes direct competition among qualified manufacturers to ensure optimal product availability and clinical suitability over socioeconomic targeting, aligning with the VA’s urgent need for uninterrupted pharmaceutical access. Her primary focus is on NAICS 325412—Pharmaceutical Preparation Manufacturing—where she specializes in the acquisition of oral solid dosage forms, injectables, and other therapeutically classified medications. Duggar brings deep technical expertise in pharmaceutical regulatory compliance, lot traceability, and supply chain integrity, ensuring all procurements meet FDA and VA Formulary requirements.
Key Metrics
Total Contracts
3
Associated contracts
Industries
1
NAICS categories
Procurement Analytics
Where this contracting officer directs award activity across Nac Pharmaceuticals (36E797), by industry and small-business set-aside program.
Spending Trends
Spending Trends
Coming Soon
Works with
3 contracting officers at Nac Pharmaceuticals (36E797)
Recent Solicitations
Opportunities Youlanda Duggar is the point of contact for
Reach the people behind Nac Pharmaceuticals (36E797) awards
Know who buys, what they buy, and when they buy it again
Contract history and award activity for Youlanda Duggar
Contact details and the offices each officer buys for
AI-powered matching between their requirements and your capabilities
Automated alerts when they post a new opportunity
Join 750+ contractors already using CLEATUS

